JPRN-jRCTs031190227已完成2 期
A prospective multi-center open trial to evaluate the safety and efficacy of triple combination therapy of lopinavir , ritonavir and hydroxychloroquine sulfate in patients infected with COVID-19.
Tokue Yutaka0 个研究点目标入组 0 人开始时间: 2020年2月27日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
Since the efficacy of lopinavir, ritonavir, and hydroxychloroquine sulfate was not shown in the research reports from overseas, the recruitment was suspended on June 2, 2020 without any cases. No results were obtained after that because there were no cases.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •positive result for COVID-19 detection test
- •fever above 37.5 degree Celsius, or pneumonia shadow on chest X-ray or CT-scan
- •hospital admission
排除标准
- •past history of hypersensitivity to lopinavir, ritonavir, hydroxychloroquine or oseltamivir
研究者
相似试验
Unknown
4 期
The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia2019-nCoV Severe PneumoniaNCT04263402Tongji Hospital100
Unknown
4 期
A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia2019-nCoVNCT04254874Tongji Hospital100
Unknown
4 期
A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia2019-nCoVNCT04255017Tongji Hospital400
已完成
3 期
GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 InfectionHIV InfectionsNCT00105079Hoffmann-La Roche337
终止
2 期
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)COVID-19NCT04307693Asan Medical Center65